A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands

Valeria Pittalà, Maria Modica, Giuseppe Romeo, Luisa Materia, Loredana Salerno, Mariangela Siracusa, Alfredo Cagnotto, Ilario Mereghetti, Filippo Russo

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, acute myocardial infarction, congestive heart failure, renal failure, pulmonary hypertension, and atherosclerosis. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ETA) and endothelin B (ET B), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an "hit compound" with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (29-52) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ETA and ETB receptors.

Original languageEnglish
Pages (from-to)711-720
Number of pages10
JournalFarmaco
Volume60
Issue number9
DOIs
Publication statusPublished - Sep 2005

Fingerprint

Endothelin Receptors
Endothelins
Ligands
Endothelin A Receptors
Radioligand Assay
CHO Cells
Pulmonary Hypertension
Renal Insufficiency
pyridine
Atherosclerosis
Heart Failure
Myocardial Infarction
Hypertension

Keywords

  • 2-Carboxamido-3-carboxythiophene derivatives
  • 4,5,6,7-Tetrahydrothieno[2,3-c]pyridine
  • Endothelin receptors
  • G Protein-coupled receptors
  • Hypertension

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmaceutical Science

Cite this

A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands. / Pittalà, Valeria; Modica, Maria; Romeo, Giuseppe; Materia, Luisa; Salerno, Loredana; Siracusa, Mariangela; Cagnotto, Alfredo; Mereghetti, Ilario; Russo, Filippo.

In: Farmaco, Vol. 60, No. 9, 09.2005, p. 711-720.

Research output: Contribution to journalArticle

Pittalà, Valeria ; Modica, Maria ; Romeo, Giuseppe ; Materia, Luisa ; Salerno, Loredana ; Siracusa, Mariangela ; Cagnotto, Alfredo ; Mereghetti, Ilario ; Russo, Filippo. / A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands. In: Farmaco. 2005 ; Vol. 60, No. 9. pp. 711-720.
@article{7ce9078980d94b44a6fa9e3fc9ca83c9,
title = "A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands",
abstract = "Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, acute myocardial infarction, congestive heart failure, renal failure, pulmonary hypertension, and atherosclerosis. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ETA) and endothelin B (ET B), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an {"}hit compound{"} with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (29-52) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ETA and ETB receptors.",
keywords = "2-Carboxamido-3-carboxythiophene derivatives, 4,5,6,7-Tetrahydrothieno[2,3-c]pyridine, Endothelin receptors, G Protein-coupled receptors, Hypertension",
author = "Valeria Pittal{\`a} and Maria Modica and Giuseppe Romeo and Luisa Materia and Loredana Salerno and Mariangela Siracusa and Alfredo Cagnotto and Ilario Mereghetti and Filippo Russo",
year = "2005",
month = "9",
doi = "10.1016/j.farmac.2005.06.005",
language = "English",
volume = "60",
pages = "711--720",
journal = "Farmaco",
issn = "0014-827X",
publisher = "Societa chimica italiana",
number = "9",

}

TY - JOUR

T1 - A facile synthesis of new 2-carboxamido-3-carboxythiophene and 4,5,6,7-tetrahydro-2-carboxamido-3-carboxythieno[2,3-c]pyridine derivatives as potential endothelin receptors ligands

AU - Pittalà, Valeria

AU - Modica, Maria

AU - Romeo, Giuseppe

AU - Materia, Luisa

AU - Salerno, Loredana

AU - Siracusa, Mariangela

AU - Cagnotto, Alfredo

AU - Mereghetti, Ilario

AU - Russo, Filippo

PY - 2005/9

Y1 - 2005/9

N2 - Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, acute myocardial infarction, congestive heart failure, renal failure, pulmonary hypertension, and atherosclerosis. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ETA) and endothelin B (ET B), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an "hit compound" with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (29-52) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ETA and ETB receptors.

AB - Endothelins (ETs) are the most ubiquitous, highly potent and unusually long-lasting peptidic constrictors of human vessels known. Elevated levels of the plasma concentration of ETs were observed in several diseases such as hypertension, acute myocardial infarction, congestive heart failure, renal failure, pulmonary hypertension, and atherosclerosis. ETs exert their activities via specific seven-transmembrane, G protein-coupled receptors. To date two receptor subtypes, endothelin A (ETA) and endothelin B (ET B), have been identified and cloned. A literature survey revealed that a number of compounds that bind ET receptors with affinity and selectivity are known, nevertheless these compounds belong only to few chemical classes. The aim of this work is the identification of an "hit compound" with novel chemical structure endowed with reasonable ET affinity and selectivity. Accordingly, new variously substituted 2-carboxamido-3-carboxythiophene derivatives (29-52) were synthesized. These compounds were tested for their ability to inhibit ETs binding in radioligand binding assay using CHO cells stably expressing human ETA and ETB receptors.

KW - 2-Carboxamido-3-carboxythiophene derivatives

KW - 4,5,6,7-Tetrahydrothieno[2,3-c]pyridine

KW - Endothelin receptors

KW - G Protein-coupled receptors

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=24944536619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944536619&partnerID=8YFLogxK

U2 - 10.1016/j.farmac.2005.06.005

DO - 10.1016/j.farmac.2005.06.005

M3 - Article

VL - 60

SP - 711

EP - 720

JO - Farmaco

JF - Farmaco

SN - 0014-827X

IS - 9

ER -